Table 4.
Sequela in children with symptomatic congenital CMV infection identified based on newborn screening (screened) or clinical suspicion (referred)
| Screened (N=78) | Referred (N=100) | P-value | |
|---|---|---|---|
| Positive/ Total Examined (%) | |||
| Sensorineural Hearing Loss | 28/78 (36) | 52/93 (56) | 0.009 |
| Progressive | 15/28 (54) | 28/52 (54) | NS |
| Delayed | 10/28 (36) | 13/52 (25) | NS |
| Bilateral | 14/28 (50) | 39/52 (75) | 0.02 |
| IQ<70 | 10/40 (25) | 28/60 (47) | 0.03 |
| Motor Abnormalities | 11/70 (16) | 27/99 (27) | NS |
| Chorioretinitis | 7/77 (9) | 16/89 (18) | NS |
| Seizures | 9/78 (11) | 23/98 (23) | 0.04 |
| No Sequelae | 36/71 (51) | 24/86 (28) | 0.003 |
| One Sequelae | 19/71 (27) | 26/86 (30) | NS |
| Two Or More Sequelae | 16/71 (21) | 36/86 (42) | 0.01 |